Leonard White
Overview
Explore the profile of Leonard White including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tian Y, Johnson G, Williams R, White L
bioRxiv
. 2023 Jun;
PMID: 37292796
Information on regional variation in cell numbers and densities in the CNS provides critical insight into structure, function, and the progression of CNS diseases. However, variability can be real or...
2.
Li J, Middleton D, Chen S, White L, Corado C, Vite C, et al.
Neuroradiol J
. 2018 Jan;
31(2):168-176.
PMID: 29350082
Purpose The purpose of this study was to compare quantitative diffusion tensor imaging metrics in dogs affected with a model of Krabbe disease to age-matched normal controls. We hypothesized that...
3.
Li J, Middleton D, Chen S, White L, Ellinwood N, Dickson P, et al.
Neuroradiol J
. 2017 Jun;
30(4):339-346.
PMID: 28627967
Purpose We describe a novel technique for measuring diffusion tensor imaging metrics in the canine brain. We hypothesized that a standard method for region of interest placement could be developed...
4.
Choi J, Dickson P, Calabrese E, Chen S, White L, Ellingwood M, et al.
Neuroradiol J
. 2015 Oct;
28(6):562-73.
PMID: 26475483
Objective: This study examined the effect of mucopolysaccharidosis (MPS) type 1 on diffusion tensor imaging (DTI) metrics in the canine brain. We hypothesized 1) white matter regions in the MPS...
5.
Kabbinavar F, Fehrenbacher L, Hainsworth J, Kasubhai S, Kressel B, Marsland T, et al.
J Thorac Oncol
. 2014 Aug;
9(9):1411-7.
PMID: 25122437
Introduction: ATLAS compared bevacizumab plus erlotinib (B+E) with bevacizumab plus placebo (B+P) as maintenance therapy after first-line bevacizumab plus chemotherapy (B+C) for advanced non-small-cell lung cancer (NSCLC). Prespecified biomarkers were...
6.
Wei P, Leong D, Calabrese E, White L, Pierce T, Platt S, et al.
Neuroradiol J
. 2013 Nov;
26(5):501-10.
PMID: 24199809
This study examined the relationship between histological variables and diffusion tensor imaging (DTI) values in a normal canine brain. We hypothesized that radial diffusivity (RD) would correlate with myelin density...
7.
Johnson B, Kabbinavar F, Fehrenbacher L, Hainsworth J, Kasubhai S, Kressel B, et al.
J Clin Oncol
. 2013 Oct;
31(31):3926-34.
PMID: 24101054
Purpose: This phase III trial was performed to assess the potential benefit of adding maintenance erlotinib to bevacizumab after a first-line chemotherapy regimen with bevacizumab for advanced non-small-cell lung cancer...
8.
Kelley M, White L, Compton M, Harvey P
Psychiatry Res
. 2012 Sep;
205(1-2):137-42.
PMID: 22974521
Although the items of the Positive and Negative Syndrome Scale (PANSS) are ordinal, continuous data methods are consistently used to analyze them. The current study addresses this issue by applying...
9.
Ying Tang C, Friedman J, Carpenter D, Novakovic V, Eaves E, Ng J, et al.
Schizophr Res
. 2011 Jun;
130(1-3):94-100.
PMID: 21641187
Recently, the negative effects of hypertension and elevated body mass index on cognitive functioning in schizophrenia have been reported (Friedman et al., 2010). Data suggests that cognitive changes in hypertensive...
10.
Friedman J, Lindenmayer J, Alcantara F, Bowler S, Parak M, White L, et al.
Neuropsychopharmacology
. 2011 Feb;
36(6):1289-95.
PMID: 21346734
Despite its superior efficacy, clozapine is helpful in only a subset of patients with schizophrenia unresponsive to other antipsychotics. This lack of complete success has prompted the frequent use of...